Segall Bryant & Hamill’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-37,455	Closed	-$2.73M	–	502
2023 Q3	$2.73M	Buy	37,455 +100	+0.3%	+$7.99K	0.03%	386
2023 Q2	$3.11M	Sell	37,355 -226	-0.6%	-$18.9K	0.03%	393
2023 Q1	$2.86M	Buy	37,581 +800	+2%	+$66.4K	0.03%	399
2022 Q4	$3.05M	Sell	36,781 -243	-0.7%	-$19.7K	0.03%	384
2022 Q3	$2.95M	Hold	37,024	–	–	0.04%	387
2022 Q2	$2.75M	Sell	37,024 -226	-0.6%	-$17K	0.03%	397
2022 Q1	$3.35M	Buy	+37,250	New	+$3.44M	0.03%	390
2021 Q4	–	Sell	-19,550	Closed	-$2.46M	–	774
2021 Q3	$2.46M	Sell	19,550 -115	-0.6%	-$14.8K	0.02%	442
2021 Q2	$2.67M	Buy	19,665 +17,727	+915%	+$2.33M	0.03%	435
2021 Q1	$263K	Hold	1,938	–	–	﹤0.01%	748
2020 Q4	$272K	Hold	1,938	–	–	﹤0.01%	664
2020 Q3	$216K	Sell	1,938 -75	-4%	-$8.41K	﹤0.01%	668
2020 Q2	$225K	Buy	+2,013	New	+$198K	﹤0.01%	733
2016 Q2	–	Sell	-51,223	Closed	-$2.65M	–	564
2016 Q1	$2.65M	Hold	51,223	–	–	0.07%	267
2015 Q4	$3.6M	Hold	51,223	–	–	0.09%	249
2015 Q3	$3.19M	Buy	+51,223	New	+$4.04M	0.08%	260